TAAR1 and schizophrenia: Thus, it is not surprising that TAAR1 has been shown to affect dopaminergic, serotonergic and glutamatergic signaling and consequently modulate aspects of reward-processing, cognition and mood relevant to schizophrenia and other psychiatric disorders [38, 39].